Optizyme
Natural health product licensed in Canada
- Licence holder
- Naturo Aid Pharmaceutical Inc.
- NPN or DIN-HM
- 80034407
- Status
- Active licence
- Licence date
- 3 August 2012
- Revision date
- 9 December 2025
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| bêta-galactosidase Source : Aspergillus oryzae - En entier | 13 mg | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger - En entier | 8 mg | Not calculated |
| papaïne Source : Papaya (Carica papaya) fruit/latex | 50 mg | Not calculated |
| Protéase Source : Aspergillus oryzae - En entier | 23 FCC SAPU | Not calculated |
| Protéase Source : Aspergillus oryzae - En entier | 11.5 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus oryzae - En entier | 17,500 FCC DU | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus oryzae - En entier | 175 mg | Not calculated |
| papaïne Source : Papaya (Carica papaya) fruit/latex | 100,000 FCC PU | Not calculated |
| Protéase Source : Aspergillus oryzae - En entier | 22,500 FCC HUT | Not calculated |
| Protéase Source : Aspergillus oryzae - En entier | 45 mg | Not calculated |
| bêta-galactosidase Source : Aspergillus oryzae - En entier | 650 ALU | Not calculated |
| alpha-L-arabinofuranoside arabinofuranohydrolase Source : Aspergillus niger - En entier | 30 FCC HCU | Not calculated |
| bêta-D-fructofuranoside fructohydrolase Source : Saccharomyces cerevisiae - cellule entière | 213 FCC SU | Not calculated |
| myo-Inositol-hexakisphosphate 3-phosphohydrolase Source : Aspergillus niger - En entier | 10.8 mg | Not calculated |
| Bromélaïne de tige Source : Ananas comosus - Tige | 120 GDU | Not calculated |
Non-medicinal ingredients
Palmitate d'ascorbyle, Microcrystalline cellulose, Pullulane, L-leucine, Dioxyde de silicium, Maltodextrine, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Optizyme is a blend of digestive enzymes. Contains alpha-galactosidase that helps reduce gas production/flatulence following a meal rich in fermentable carbohydrates (such as vegetables, pulses/legumes/beans and whole grains) and prevent gastrointestinal intolerance of oligosaccharides/fermentable carbohydrates.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80034407
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.